Tag: ABBV
-
2 Pharmaceutical Stocks Positioned for the Next Growth Cycle
For investors willing to look past the GLP-1 spotlight, MRK and ABBV offer exposure to the next chapter in pharmaceutical stocks,
-
4 Income ETFs That Could Help Investors Navigate Market Volatility
Consider these four income ETFs to help diversify and safeguard your portfolio from market volatility.
-
3 High-Yield Dividend ETFs to Protect Your Portfolio
In times of chaos, dividend ETFs can offer investors a compelling mix of stability, passive income, and long-term growth.
-
3 Top Dividend ETFs to Buy for Income, Stability, and Long-Term Growth
Looking for income and stability? These three dividend ETFs offer reliable yields, quality holdings, and long-term growth potential.
-
AbbVie vs. JNJ: Which Biopharma Stock Wins in 2026?
Biopharma stocks may benefit from sector rotation. AbbVie and Johnson & Johnson deserve a close look, but they are not the same trade.
-
3 High-Yield Dividend ETFs to Protect Your Portfolio From Market Volatility
In times of market volatility, investors can strengthen their portfolios by incorporating diversified, income-producing dividend ETFs.
-
3 Safe ETFs to Buy Now as Market Volatility Rises
Instead of sitting in cash or trying to time the market, investors may find opportunities in safe ETFs that follow strategies favored by Warren Buffett.
-
AbbVie Q1 2026 Earnings: Skyrizi and Rinvoq Drive Record Growth
AbbVie’s Q1 results confirm that its post-Humira growth platform is accelerating, and management’s decision to raise full-year guidance reflects that optimism.
-
Protect Your Portfolio with 3 High-Yielding Dividend ETFs
In uncertain markets, dividend ETFs —especially those emphasizing companies with long histories of growing payouts—can help anchor your portfolio.
-
3 ETFs to Build Income and Wealth Over Time
Exchange-traded funds (ETFs) remain an efficient way for investors to build long-term wealth with steady dividend income that can compound over time.